Skip to content

This round closed on 6 October 2026. The details below are from that round.

Browse open KWF calls.

KWF

Development Call

12:00 noon; Full proposal deadline 16 March 2027, 12:00 noon

Last seen in a scan/import: .

Catalog updated: .

These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.

Closed for now. See which open grants match your research. 30s, no email. See my matches →

The KWF Development Call funds Dutch cancer researchers to advance projects across all research phases, from creating new modalities through clinical and implementation stages, with a focus on translational impact. The call is open to Research Projects, Unique High-Risk proposals, and Consortia, with a mandatory development plan outlining steps, stakeholders, feasibility, and risk mitigation. Two-stage review (pre-proposal then full proposal) runs annually, with PACO (patient and charity organisation) input weighted at 30% of the evaluation.

Details

Funder KWF
Consortium Optional — KWF encourages collaboration with private enterprises (public-private partnership) when relevant for product development and implementation; Consortium application type available
Application 2-stage: pre-proposal (deadline 6 October 2026) → full proposal (deadline 16 March 2027), consortium interviews May 2027, funding decision July 2027
Frequency Annual
Next round 2027-07
Eligible countries NL

Eligibility & scope

Supports translation of cancer research findings into practical implementation via Research Project, Unique High-Risk, or Consortia application types, covering Creation of Modality, Preclinical, Clinical or Implementation research phases. Requires a development plan with feasibility assessment and risk analysis; GI cancer multicenter trials need a national research group support letter at full-proposal stage.

Who Should Apply

  • •Researchers based at Dutch academic, hospital, or recognised research institutions
  • •All application types: single Research Projects, Unique High-Risk proposals, or multi-partner Consortia
  • •Cancer research spanning creation of modality, preclinical, clinical, and implementation phases
  • •Projects with clear development pathway and stakeholder engagement beyond academia
  • •Applicants not submitting to competing thematic calls (biomarker validation, PIPELINE, INTER-LOCAL, pancreatic screening)

Key Dates

  • •Pre-proposal deadline: 6 October 2026 at 12:00 noon (opens 28 July 2026)
  • •Full proposal deadline: 16 March 2027 at 12:00 noon (opens January 2027)
  • •Consortium interviews in May 2027; funding decision July 2027

Tips for Applicants

  • ✓Include a genuine development plan with concrete steps, identified stakeholders, and explicit risk mitigation, this is mandatory and shapes early triage.
  • ✓Patient and charity organisation input (PACO) counts for 30% of the score; draft your lay summary and patient engagement section with care, not as an afterthought.
  • ✓If applying as a Consortium, prepare for interview in May 2027; single Research Project and High-Risk proposals do not require interview, reducing burden.

Frequently Asked Questions

What types of cancer research does the KWF Development Call fund?

The call is open to research across all cancer types and phases: creation of modality, preclinical, clinical, and implementation. Projects must exclude those falling within specific thematic calls (biomarker validation, PIPELINE, INTER-LOCAL, pancreatic screening).

Can I apply as a consortium to the KWF Development Call?

Yes, the call accepts Research Projects, Unique High-Risk proposals, and multi-partner Consortia. Consortium applications require an interview in May 2027; other application types do not.

What is the pre-proposal and full proposal timeline?

Pre-proposal deadline is 6 October 2026 at 12:00 noon; full proposal deadline is 16 March 2027 at 12:00 noon. Funding decisions are expected in July 2027.

How much weight does patient and charity input have in KWF Development Call review?

Patient and charity organisation (PACO) review is weighted at 30% of the overall evaluation score.

Who is eligible to apply to the KWF Development Call?

Researchers based at Dutch academic, hospital, or recognised research institutions are eligible.

cancer-biologykwftranslationalnetherlandsdevelopment-granttwo-stagepatient-engagement

Related on Grantsby

Summary generated by AI based on published grant information. Always verify details on the funder's website.

Similar grants

Browse all open grants →

Browse Related

This call has closed. See what's open now.

Get matched against every open call from KWF and the rest of the 65 funders we track, rechecked every week. 30 seconds, no signup needed to preview.

See my matches free →